(Q37958283)

25 August 2017

0 references

Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis (English)

1 reference

25 August 2017

0 references

cardiovascular disease

1 reference

1 reference

Peter Higgins

1

1 reference

25 August 2017

Jesse Dawson

2

1 reference

25 August 2017

Kennedy R Lees

3

1 reference

25 August 2017

Kate McArthur

4

1 reference

25 August 2017

Terrence J Quinn

5

1 reference

25 August 2017

Matthew R Walters

6

1 reference

25 August 2017

publication date

12 June 2011

1 reference

Cardiovascular Therapeutics

25 August 2017

published in

1 reference

25 August 2017

volume

30

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

217-226

1 reference

One-year cardiovascular event rates in outpatients with atherothrombosis.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

The impact of serum uric acid on cardiovascular outcomes in the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Role of oxidative stress in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Allopurinol treatment reduces arterial wave reflection in stroke survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Effect of Allopurinol Pretreatment on Free Radical Generation after Primary Coronary Angioplasty for Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Implication of xanthine oxidase in muscle oxidative stress in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Xanthine oxidase does not contribute to impaired peripheral conduit artery endothelium-dependent dilatation with ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Allopurinol improves endothelial dysfunction in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

A placebo-controlled study examining the effect of allopurinol on heart rate variability and dysrhythmia counts in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Allopurinol and mortality in hyperuricaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Association between allopurinol and mortality in heart failure patients: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Gout, allopurinol use, and heart failure outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

The clinical implications of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00277.X

10.1111/J.1755-5922.2011.00277.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference